- 2023 - 2027 フローサイトメトリー法を用いた抗体医薬品の一斉測定法の新規開発と臨床応用
- 2022 - 2025 The search for novel risk factors of BK polyomavirus infection after kidney transplantation
- 2022 - 2025 Exploratory study in immunoadjuvant therapy for pediatric acute myeloid leukemia
- 2020 - 2023 Research on practical use of personalized targeting therapy in cancer using pharmacogenomic information and TDM
- 2017 - 2020 Development of novel preventive method for cisplatin-induced nephrotoxicity with drug-drug interaction
- 2016 - 2019 Construction of PK/PD evaluation system for optimizing treatment using immune checkpoint inhibitors
- 2014 - 2017 Role of microRNA on the pharmacokinetics and pharmacodynamics of tacrolimus in inflammatory bowel disease
- 2014 - 2017 Role of microRNA on the pharmacokinetics of calcineurin inhibitors after living liver transplantation
- 2012 - 2015 Risk evaluation of carboplatin-induced allergy based on basophil activation test and FceRI expression.
- 2013 - 2015 白血球との親和性・反応性を指標とした抗体医薬品の治療モニタリング法の開発
- 2013 - 2015 リンパ球の免疫応答性を指標とした腎移植の免疫抑制療法の評価系構築
- 2011 - 2013 Regulation of functions of drug transporters in renal tubules by inflammatory cytokines and implication of its significance
- 2010 - 2011 好塩基球の活性化を指標としたカルボプラチン過敏症の予測系の構築
- 2010 - 2011 Basic research for the prevention of cisplatin-induced renal toxicity based on the characteristics of renal tubular transport of its cytotoxic metabolite
- 2008 - 2010 Expression and functions of drug transporters in renal tubules by kidney-specific oxidative stress and its role
- 2005 - 2005 紫外線照射下の医薬品のヒト遺伝子損傷性を指標とした安全性評価
- 2004 - 2004 アンプリファイヤーによる抗がん剤のDNA切断および細胞死の増強機構の解明
Show all